S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Tens of thousands of Colombians protest against the leftist president's reform agenda
OTCMKTS:CVAT

Cavitation Technologies (CVAT) Stock Price, News & Analysis

$0.01
0.00 (0.00%)
(As of 04/19/2024 ET)
Today's Range
$0.0113
$0.0120
50-Day Range
$0.01
$0.0174
52-Week Range
$0.01
$0.04
Volume
200,000 shs
Average Volume
177,894 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CVAT stock logo

About Cavitation Technologies Stock (OTCMKTS:CVAT)

Cavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in the processing of various industrial and consumer-oriented fluids in the United States. It provides Nano Reactor and Nano Neutralization Systems for refining vegetable oils, such as soybean, rapeseed, canola, and palm oil. The company also develops technology-based systems for various markets, including renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions, and crude oil yield enhancement, as well as small home appliances. Cavitation Technologies, Inc. was founded in 2007 and is headquartered in Chatsworth, California.

CVAT Stock Price History

CVAT Stock News Headlines

Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Cavitation Techs Inc (CVAT)
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Cavitation Technologies, Inc. Provides Corporate Update
See More Headlines
Receive CVAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cavitation Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/21/2024
Next Earnings (Estimated)
5/12/2024

Industry, Sector and Symbol

Industry
Specialty Industrial Machinery
Sub-Industry
N/A
Current Symbol
OTCMKTS:CVAT
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Naum D. Voloshin (Age 60)
    President, CEO, CFO, Principal Accounting Officer, Secretary & Director
    Comp: $203.14k
  • Mr. Maxim Promtov
    Head of Research and Director of Research & Development
  • Mr. Roman Gordon (Age 74)
    Co-Founder & Global Technology Manager
    Comp: $169k

CVAT Stock Analysis - Frequently Asked Questions

How have CVAT shares performed in 2024?

Cavitation Technologies' stock was trading at $0.0163 on January 1st, 2024. Since then, CVAT stock has decreased by 30.7% and is now trading at $0.0113.
View the best growth stocks for 2024 here
.

When is Cavitation Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Sunday, May 12th 2024.
View our CVAT earnings forecast
.

What other stocks do shareholders of Cavitation Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cavitation Technologies investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).

How do I buy shares of Cavitation Technologies?

Shares of CVAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CVAT) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners